Annual EBITDA
-$290.98M$330.87M-829.45%
Summary
- Current Value
- As of today, AMLX annual EBITDA is -$290.98M, down -829.45% on
- Historical Performance
- AMLX annual EBITDA is down -252.12% over the past 3 years, and down -2239.04% over the past 5 years
- All-Time High Comparison
- AMLX annual EBITDA is currently -829.45% below its historical high of $39.89M set on
- 3-Year Low Comparison
- AMLX annual EBITDA is at its 3-year low
- Sector Comparison
- AMLX annual EBITDA is higher than 4.17% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$290.98M | -829.5% | -252.1% | -2239.0% | -2239.0% | |
| Quarterly EBITDA | -$35.91M | +8.5% | +34.1% | – | – | |
| TTM EBITDA | -$156.76M | +26.1% | +15.1% | – | – | |
| Price | $16.92 | +390.4% | -54.1% | – | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $87.37M | -77.1% | +10000.0% | +6027.0% | +6027.0% | |
| Annual EPS | -$4.43 | -729.0% | -191.4% | -1723.0% | -1723.0% | |
| Annual EBIT | -$291.88M | -852.2% | -253.0% | -2246.3% | -2246.3% | |
| Annual Net Income | -$301.74M | -712.4% | -243.2% | -2099.9% | -2099.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $39.89M | -829.5% | |
| 5Y | $39.89M | -829.5% | |
| All | $39.89M | -829.5% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$290.98M | at low | |
| 5Y | -$290.98M | at low | |
| All | -$290.98M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$290.98M | -829.4% | |
| $39.89M | +119.9% | |
| -$200.85M | -143.1% |
| Year | Value | Change |
|---|---|---|
| -$82.64M | -106.6% | |
| -$39.99M | -221.5% | |
| -$12.44M | - |
FAQ
What is the current annual EBITDA of AMLX?
As of today, AMLX annual EBITDA is -$290.98M
What is 1-year change in AMLX annual EBITDA?
AMLX annual EBITDA is down -829.45% year-over-year
What is 3-year change in AMLX annual EBITDA?
AMLX annual EBITDA is down -252.12% over the past 3 years
How far is AMLX annual EBITDA from its all-time high?
AMLX annual EBITDA is currently -829.45% below its historical high of $39.89M set on December 31, 2023
How does AMLX annual EBITDA rank versus sector peers?
AMLX annual EBITDA is higher than 4.17% of companies in Healthcare sector
When is AMLX next annual earnings release?
The next annual earnings release for AMLX is on
Quarterly EBITDA
-$35.91M$6.81M+15.94%
Summary
- Current Value
- As of today, AMLX quarterly EBITDA is -$35.91M, up +15.94% on
- Historical Performance
- AMLX quarterly EBITDA is up +8.49% year-over-year, and up +34.13% over the past 3 years
- All-Time High Comparison
- AMLX quarterly EBITDA is currently -275.31% below its historical high of $20.48M set on
- 3-Year Low Comparison
- AMLX quarterly EBITDA is +70.52% above its 3-year low of -$121.82M reached on
- Sector Comparison
- AMLX quarterly EBITDA is higher than 11.87% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$35.91M | +15.9% | +8.5% | +34.1% | – | |
| Annual EBITDA | -$290.98M | – | -829.5% | -252.1% | -2239.0% | |
| TTM EBITDA | -$156.76M | +2.1% | +26.1% | +15.1% | – | |
| Price | $16.92 | +10.7% | +390.4% | -54.1% | – | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $0.00 | 0.0% | -100.0% | -100.0% | 0.0% | |
| Quarterly EPS | -$0.37 | +20.8% | +65.5% | +59.9% | -100.0% | |
| Quarterly EBIT | -$36.03M | +15.9% | +8.7% | +34.1% | -100.0% | |
| Quarterly Net Income | -$34.39M | +17.0% | +52.7% | +36.0% | -100.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$35.91M | at high | |
| 3Y | $20.48M | -275.3% | |
| 5Y | $20.48M | -275.3% | |
| All | $20.48M | -275.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$42.72M | +15.9% | |
| 3Y | -$121.82M | +70.5% | |
| 5Y | -$121.82M | +70.5% | |
| All | -$121.82M | +70.5% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of AMLX?
As of today, AMLX quarterly EBITDA is -$35.91M
What is AMLX quarterly EBITDA most recent change?
AMLX quarterly EBITDA was up +15.94% on September 30, 2025
What is 1-year change in AMLX quarterly EBITDA?
AMLX quarterly EBITDA is up +8.49% year-over-year
How far is AMLX quarterly EBITDA from its all-time high?
AMLX quarterly EBITDA is currently -275.31% below its historical high of $20.48M set on June 30, 2023
How does AMLX quarterly EBITDA rank versus sector peers?
AMLX quarterly EBITDA is higher than 11.87% of companies in Healthcare sector
When is AMLX next earnings release?
The next earnings release for AMLX is on
TTM EBITDA
-$156.76M$3.33M+2.08%
Summary
- Current Value
- As of today, AMLX TTM EBITDA is -$156.76M, up +2.08% on
- Historical Performance
- AMLX TTM EBITDA is up +26.07% year-over-year, and up +15.14% over the past 3 years
- All-Time High Comparison
- AMLX TTM EBITDA is currently -492.99% below its historical high of $39.89M set on
- 3-Year Low Comparison
- AMLX TTM EBITDA is +38.47% above its 3-year low of -$254.77M reached on
- Sector Comparison
- AMLX TTM EBITDA is higher than 10.33% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$156.76M | +2.1% | +26.1% | +15.1% | – | |
| Annual EBITDA | -$290.98M | – | -829.5% | -252.1% | -2239.0% | |
| Quarterly EBITDA | -$35.91M | +15.9% | +8.5% | +34.1% | – | |
| Price | $16.92 | +10.7% | +390.4% | -54.1% | – | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | -$665.00K | -167.1% | -100.3% | -292.8% | -100.0% | |
| TTM EPS | -$1.80 | +28.0% | +52.9% | +43.0% | -100.0% | |
| TTM EBIT | -$157.34M | +2.1% | +26.2% | +15.0% | -100.0% | |
| TTM Net Income | -$149.28M | +20.4% | +42.5% | +18.9% | -100.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$156.76M | at high | |
| 3Y | $39.89M | -493.0% | |
| 5Y | $39.89M | -493.0% | |
| All | $39.89M | -493.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$254.77M | N/A | +38.5% |
| 3Y | -$254.77M | +38.5% | |
| 5Y | -$254.77M | +38.5% | |
| All | -$254.77M | +38.5% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of AMLX?
As of today, AMLX TTM EBITDA is -$156.76M
What is AMLX TTM EBITDA most recent change?
AMLX TTM EBITDA was up +2.08% on September 30, 2025
What is 1-year change in AMLX TTM EBITDA?
AMLX TTM EBITDA is up +26.07% year-over-year
How far is AMLX TTM EBITDA from its all-time high?
AMLX TTM EBITDA is currently -492.99% below its historical high of $39.89M set on December 31, 2023
How does AMLX TTM EBITDA rank versus sector peers?
AMLX TTM EBITDA is higher than 10.33% of companies in Healthcare sector
When is AMLX next earnings release?
The next earnings release for AMLX is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- AMLX Official Website amylyx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1658551/000119312525268059/0001193125-25-268059-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1658551/000095017025031309/0000950170-25-031309-index.htm
- AMLX Profile on Yahoo Finance finance.yahoo.com/quote/AMLX
- AMLX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/amlx